Lung Cancer News

Individuals with therapy-refractory cancer who received waivers to participate in a clinical trial for off-label targeted therapies achieved similar clinical benefits as those who took part in the study without an exception.

The risk for lung cancer has been found to be particularly high in some Maryland counties, but a recently launched initiative is making sure screening is available for all eligible state residents, according to a press release.

Robert A. Winn, MD, FAACR, first called for celebration.

Potential risk factors for lung cancer reoccurrence within 2 years include obstructive sleep apnea-related episodic hypoxemia and hypoxic burden, according to research presented at SLEEP 2024.

Discussion about lung cancer research breakthroughs dominated the social media conversation among health care professionals during this year’s ASCO Annual Meeting.

In this edition, screening program identifies airways disease in previously undiagnosed COPD, positive results show benefits of subcutaneous bispecifics and more.

A new clinic at The Ohio State University — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Pelotonia Institute for Immuno-Oncology seeks to minimize the autoimmune effects of immunotherapy cancer treatment.

Air pollution exposure may contribute to both CV and cancer risk by interacting with various common risk factors such as inflammation, oxidative stress and epigenetic modifications, according to a state-of-the-art review.

The American Cancer Society has launched VOICES of Black Women, a large long-term population study of cancer risk and outcomes among Black women in the United States.

The FDA granted accelerated approval to repotrectinib for the treatment of adults and children 12 years and older with solid tumors that have a neurotrophic tyrosine receptor kinase gene fusion.